###begin article-title 0
###xml 40 46 40 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
Tissue-specific alternative splicing of TCF7L2
###end article-title 0
###begin p 1
###xml 54 61 54 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2)</italic>
###xml 327 333 327 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 634 640 634 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 978 979 978 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1006 1007 1006 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1137 1138 1137 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1166 1167 1166 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1298 1299 1298 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 1299 1300 1299 1300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1314 1315 1314 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1407 1413 1407 1413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 1489 1495 1489 1495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 1617 1623 1617 1623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 390 395 <span type="species:ncbi:9606">human</span>
###xml 1514 1519 <span type="species:ncbi:9606">human</span>
Common variants in the transcription factor 7-like 2 (TCF7L2) gene have been identified as the strongest genetic risk factors for type 2 diabetes (T2D). However, the mechanisms by which these non-coding variants increase risk for T2D are not well-established. We used 13 expression assays to survey mRNA expression of multiple TCF7L2 splicing forms in up to 380 samples from eight types of human tissue (pancreas, pancreatic islets, colon, liver, monocytes, skeletal muscle, subcutaneous adipose tissue and lymphoblastoid cell lines) and observed a tissue-specific pattern of alternative splicing. We tested whether the expression of TCF7L2 splicing forms was associated with single nucleotide polymorphisms (SNPs), rs7903146 and rs12255372, located within introns 3 and 4 of the gene and most strongly associated with T2D. Expression of two splicing forms was lower in pancreatic islets with increasing counts of T2D-associated alleles of the SNPs: a ubiquitous splicing form (P = 0.018 for rs7903146 and P = 0.020 for rs12255372) and a splicing form found in pancreatic islets, pancreas and colon but not in other tissues tested here (P = 0.009 for rs12255372 and P = 0.053 for rs7903146). Expression of this form in glucose-stimulated pancreatic islets correlated with expression of proinsulin (r2 = 0.84-0.90, P < 0.00063). In summary, we identified a tissue-specific pattern of alternative splicing of TCF7L2. After adjustment for multiple tests, no association between expression of TCF7L2 in eight types of human tissue samples and T2D-associated genetic variants remained significant. Alternative splicing of TCF7L2 in pancreatic islets warrants future studies. GenBank Accession Numbers: FJ010164-FJ010174.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 71 77 71 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 119 124 119 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF-4</italic>
###xml 202 203 202 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C1">1</xref>
###xml 339 340 339 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C2">2</xref>
###xml 341 342 341 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C4">4</xref>
###xml 379 380 379 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C5">5</xref>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C23">23</xref>
###xml 504 505 504 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C3">3</xref>
###xml 622 624 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C24">24</xref>
###xml 625 627 625 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C25">25</xref>
###xml 708 710 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C26">26</xref>
###xml 790 796 790 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 1125 1133 1125 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in-vitro</italic>
###xml 1135 1137 1135 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C27">27</xref>
###xml 1164 1170 1164 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tcf7l2</italic>
###xml 1293 1295 1293 1295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C26">26</xref>
###xml 1383 1389 1383 1389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 1421 1423 1421 1423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C28">28</xref>
###xml 1474 1476 1474 1476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C16">16</xref>
###xml 1477 1479 1477 1479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C29">29</xref>
###xml 1507 1513 1507 1513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 1181 1186 <span type="species:ncbi:10090">mouse</span>
Common genetic variants within the transcription factor 7-like 2 gene (TCF7L2, previously known as T-cell factor 4, or TCF-4) have been strongly associated with increased risk of type 2 diabetes (T2D) (1). The association with T2D and impaired function of pancreatic islets was confirmed in several genome-wide association studies (GWAS) (2-4) and follow-up association studies (5-23). TCF7L2 is a ubiquitous protein that belongs to a family of TCF/lymphoid enhancer factor (LEF)) transcription factors (3). Prior to being associated with increased T2D risk, TCF7L2 was known as an important component of the WNT pathway (24,25) and as a regulator of the proliferative cellular compartment in the intestine (26). Several hypotheses have been proposed to explain how the genetic variants in TCF7L2 could increase T2D risk. TCF7L2 might affect the ability of pancreatic islets to produce insulin in response to stimulation by insulinotropic intestinal hormone Glucagon-Like Peptide 1 (GLP-1) or glucose. This hypothesis was based on the observations that TCF7L2 could directly regulate mRNA expression of proglucagon precursor in-vitro (27) and that the deletion of Tcf7l2 gene in a mouse knock-out model resulted in loss of gut epithelial secretory cells that produce GLP-1 and other hormones (26). In support of this hypothesis, it was demonstrated that carriers of risk variants of TCF7L2 have impaired incretin effect (28) and impaired GLP-1 stimulated insulin secretion (16,29). It is also possible that TCF7L2 has pleiotropic tissue-specific roles and alterations in one or more of these functions could lead to T2D.
###end p 3
###begin p 4
###xml 52 58 52 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 280 281 280 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C1">1</xref>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C15">15</xref>
###xml 300 306 300 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 396 397 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C1">1</xref>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C30">30</xref>
###xml 568 570 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C31">31</xref>
###xml 631 637 631 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 714 716 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C28">28</xref>
###xml 717 719 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C32">32</xref>
###xml 720 722 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C38">38</xref>
###xml 851 857 851 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 859 861 859 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C39">39</xref>
###xml 862 864 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C41">41</xref>
###xml 334 342 <span type="species:ncbi:9606">patients</span>
###xml 699 704 <span type="species:ncbi:9606">human</span>
The most significant genetic T2D association within TCF7L2 was detected for two intronic single nucleotide polymorphisms (SNPs), rs7903146 and rs12255372, located 50 kb from each other within a 92 kb linkage disequilibrium (LD) block spanning exon 4 and parts of introns 3 and 4 (1-15). All exons of TCF7L2 were sequenced in multiple patients and controls but no coding variation was identified (1) suggesting that T2D risk is associated with a non-coding variation. Genetic variations may affect levels of expression and splicing architecture of mRNA transcripts (30,31) thus several studies have tested the relationships between TCF7L2 mRNA expression and genotypes of rs7903146 and rs12255372 in human tissues (28,32-38). However, these studies have been limited by the use of small sets of samples and tissue types. Alternative exons reported for TCF7L2 (39-41) represent a potentially important source of functional molecular variation, yet the tissue specificity of the alternative splicing and its relationship with genetic variation has not been fully established.
###end p 4
###begin p 5
###xml 60 66 60 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 162 168 162 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 559 565 559 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 87 92 <span type="species:ncbi:9606">human</span>
Here, we evaluated the splicing diversity and expression of TCF7L2 in a broad range of human tissues. We provide evidence that expression of alternative exons of TCF7L2 is tissue-specific. One splicing form was unique to pancreatic islets, pancreas and colon and not found in other tissues studied. Expression of this form correlated with proinsulin expression in glucose-stimulated pancreatic islets. Our study does not provide strong evidence for association of T2D-associated SNPs rs7903146 and rs12255372 with expression of alternatively spliced forms of TCF7L2 in several tissues but points out a potentially functional biological effect in pancreatic islets. Future studies in larger sets of samples should confirm and explore this finding.
###end p 5
###begin title 6
RESULTS
###end title 6
###begin title 7
###xml 31 37 31 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7l2</italic>
###xml 41 46 <span type="species:ncbi:9606">human</span>
Expression of assay 'ex7-8' of TCF7l2 in human tissues and test for association with rs7903146 and rs12255372
###end title 7
###begin p 8
###xml 42 48 42 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP321F1">1</xref>
###xml 243 244 240 241 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 573 574 570 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP321F2">2</xref>
###xml 596 602 593 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 881 882 878 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP321TB1">1</xref>
###xml 1113 1114 1110 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP321TB1">1</xref>
###xml 1438 1439 1435 1436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP321TB1">1</xref>
###xml 157 162 <span type="species:ncbi:9606">human</span>
First, we measured the mRNA expression of TCF7L2 using an assay that targeted exons 7 and 8 of the gene (assay 'ex7-8', Fig. 1), and detected signals in all human tissues tested (). When normalized to expression of two housekeeping genes, beta2 microglobulin (B2M) and Glyceraldehyde 3-phosphate dehydrogenase (GAPDH), the highest levels of expression were found in pancreas, colon, brain, small intestine and peripheral blood monocytes. The lowest levels of expression were found in resting and activated peripheral blood T and B cells and lymphoblastoid cell lines (Fig. 2 and ). Expression of TCF7L2, measured with the assay 'ex7-8' in 311 samples of pancreas, pancreatic islets, colon, liver, monocytes and subcutaneous adipose tissue from individuals without T2D, was not associated with genotypes of the two most strongly T2D-associated SNPs, rs7903146 and rs12255372 (Table 1). On the basis of the number of samples and standard deviation in expression of assays in each tissue tested, we estimated the detectable fold difference between the groups of samples carrying the risk and non-risk alleles (Table 1). In this analysis, we had 80% power (with a type I error rate of 5%) to detect a 1.13-fold difference in expression in colon, a 1.33-fold difference in liver, a 1.37-fold difference in monocytes, 2.06-fold in skeletal muscle, a 2.34-fold difference in pancreatic islets and a 2.87-fold difference in adipose tissue (Table 1).
###end p 8
###begin p 9
###xml 103 109 103 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
Location of expression assay 'ex7-8' and associated LD block with SNPs rs7903146 and rs12255372 within TCF7L2 gene, exons are marked as black rectangles.
###end p 9
###begin p 10
###xml 31 37 31 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 118 124 118 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 41 46 <span type="species:ncbi:9606">human</span>
Expression of assay 'ex7-8' of TCF7L2 in human tissues as fold difference compared with expression level in pancreas. TCF7L2 expression is normalized to the levels of endogenous controls B2M and GAPDH (). Each tissue is represented by 1 or 2-3 pooled samples.
###end p 10
###begin p 11
###xml 67 73 67 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 124 129 <span type="species:ncbi:9606">human</span>
Estimated detectable differences in expression of assay 'ex7-8' of TCF7L2 in genotype groups of rs7903146 and rs12255372 in human tissue samples
###end p 11
###begin p 12
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aMinimal detectable difference in expression between groups of samples (with and without risk alleles), based on empirical standard deviation within each group and 5% of type 1 error.
###end p 12
###begin p 13
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 10 11 10 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
bObserved P-values, univariate linear model.
###end p 13
###begin title 14
###xml 22 28 22 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7l2</italic>
Splicing diversity of TCF7l2
###end title 14
###begin p 15
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C42">42</xref>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C44">44</xref>
###xml 409 415 409 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 953 954 953 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP321F3">3</xref>
###xml 1282 1283 1281 1282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP321F3">3</xref>
###xml 1472 1473 1470 1471 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</underline>
###xml 1488 1490 1486 1488 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ca</underline>
###xml 1491 1495 1489 1493 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cATG</underline>
###xml 1556 1558 1554 1556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C45">45</xref>
###xml 2511 2513 2509 2511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C39">39</xref>
###xml 2514 2516 2512 2514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C41">41</xref>
Since our analysis did not reveal any association between expression of TCF7L2 measured by assay 'ex7-8' and SNPs rs7903146 and rs12255372, we hypothesized that these genetic variants might be associated with alternative splicing. Members of the TCF/LEF family of transcription factors use alternative transcription start sites (TSSs) to produce functionally distinct proteins (42-44). To identify all TSS of TCF7L2, we performed 5' rapid amplification of cDNA ends (5'RACE) in an RNA pool of eight tissues (pancreas, pancreatic islets, colon, liver, monocytes, skeletal muscles, subcutaneous adipose tissue and lymphoblastoid cell lines). We identified several TSS: (1) TSS1, located at -536 bp from the first translation start site and corresponding to RefSeq sequence (NM_030756); (2) TSS2, located at position +83 bp within exon 1; (3) a cluster collectively referred as TSS3 located in the first intron of the gene (+200, +239, +302, +338 bp, Fig. 3 and ). Only transcripts initiated from the TSS1 can be translated from a start codon within exon 1 and produce protein isoforms with the ss-catenin binding domain encoded by exons 1 and 2. The next in-frame translation start site that can be used by transcripts expressed from the TSS2 and TSS3, is located within exon 3 (Fig. 3), and the resulting proteins would lack the ss-catenin binding domain. Both the main (exon 1) and the alternative translation start sites (exon 3) have weak Kozak consensus sequences, 'aaaaaaATGC' and 'ttcatcATGA', compared with a classical consensus site 'gcca/gccATGG' (45). We also performed 3'RACE in an attempt to detect alternative splicing forms of the 3'-UTRs. We did not detect any short PCR fragments corresponding to mRNA transcripts with significantly truncated 3'-UTR (data not shown). We PCR amplified, cloned and sequenced full-length cDNA fragments starting from the first translation start site within exon 1 through the end of the transcript in exon 14 (based on RefSeq NM_030756). We did not attempt to clone full-length cDNAs initiated from the TSS2 because this transcription start is embedded within exon 1 of the TSS1 form and the products would represent a mixture of transcripts. Because of low expression from the TSS3, further study of the transcripts initiated from this TSS was not pursued in detail. Sequencing of full-length cDNA clones reconfirmed several known alternative exons (3a, 4a, 12, 13, 13a and 13b) and minor in-frame inclusions of 3, 12 and 15 bp in exons 4a, 6 and 8, respectively (39-41) (). All sequences for full-length cDNA expression constructs were deposited in the GenBank (FJ010164-FJ010174, ).
###end p 15
###begin p 16
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
Structure of the N-terminal part of TCF7L2: location of the beta-catenin binding domain encoded by exons 1 and 2, and a T2D-associated LD block with SNPs rs7903146 and rs12255372. Shown: constitutive exons-black rectangles, alternative exons-white rectangles; alternative transcription starts sites TSS1, TSS2 and TSS3-arrows, potential translation starts-'ATG'.
###end p 16
###begin title 17
###xml 30 36 30 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7l2</italic>
Tissue-specific expression of TCF7l2
###end title 17
###begin p 18
###xml 39 40 39 40 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP321F4">4</xref>
###xml 76 82 76 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 791 792 791 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP321F5">5</xref>
###xml 961 967 961 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 974 975 974 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP321F5">5</xref>
###xml 1036 1037 1036 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP321F5">5</xref>
###xml 1086 1087 1086 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP321F5">5</xref>
###xml 114 119 <span type="species:ncbi:9606">human</span>
###xml 655 660 <span type="species:ncbi:9606">human</span>
###xml 1143 1148 <span type="species:ncbi:9606">human</span>
We designed 13 expression assays (Fig. 4) that targeted the majority of the TCF7L2 splicing forms, we observed in human tissues. Expression of these assays was quantified in samples from pancreas, pancreatic islets, colon, liver, monocytes, skeletal muscles, subcutaneous adipose tissue and lymphoblastoid cell lines. Expression of an alternative exon 13b (assay 'ex13-13b') was detected only in pancreatic islets, pancreas and colon and this assay was not used in the analysis that included all tissue samples. The expression of assay 'ex4-4a' was low in all tissues and was not studied further.  illustrates the diversity in expression of each assay in human tissues. We performed Principal Component Analysis (PCA) on samples from eight tissues using four sets of expression assays (Fig. 5A-D). We observed better discrimination between pancreatic islets and other tissues based on expression of assays for C-terminal alternative exons 12, 13, 13a and 14 of TCF7L2 (Fig. 5C) than those of assays detecting the N-terminal exons (Fig. 5A and B) or all expression assays together (Fig. 5D and  for relative expression of each splicing form in human tissues).
###end p 18
###begin p 19
###xml 44 50 44 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
Location of TaqMan expression assays within TCF7L2 gene. Shown: constitutive exons-black rectangles, alternative exons-white rectangles, expression assays-connected arrows.
###end p 19
###begin p 20
###xml 42 43 42 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 96 102 96 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 132 133 132 133 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 186 192 186 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 239 240 239 240 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 292 298 292 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 372 373 372 373 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 421 427 421 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 26 31 <span type="species:ncbi:9606">human</span>
PCA in 289 samples from 8 human tissues. (A) PCA based on three N-terminal expression assays of TCF7L2: 'TSS1', TSS2' and 'ex7-8'. (B) PCA based on five N-terminal expression assays for TCF7L2: 'TSS1', 'TSS2', 'TSS3', 'ex3a' and 'ex7-8'. (C) PCA based on six C-terminal expression assays for TCF7L2: 'ex11-13', 'ex11-13a', 'ex11-14', 'ex12-13', 'ex13-13a' and 'ex13-14'. (D) PCA based on all eleven expression assays for TCF7L2.
###end p 20
###begin title 21
###xml 74 80 74 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7l2</italic>
Test for association between expression of alternatively spliced forms of TCF7l2 and rs7903146 and rs12255372
###end title 21
###begin p 22
###xml 109 115 109 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 521 527 521 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 624 625 624 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 655 656 655 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 685 686 685 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 719 720 719 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 856 862 856 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 1135 1136 1135 1136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1164 1165 1164 1165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1195 1196 1195 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP321TB2">2</xref>
###xml 1223 1224 1223 1224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1252 1253 1252 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1283 1284 1283 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP321TB2">2</xref>
###xml 1294 1295 1294 1295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP321F6">6</xref>
###xml 551 556 <span type="species:ncbi:9606">human</span>
In each tissue, we used all available covariates (age, sex, BMI, etc.) to identify factors that could affect TCF7L2 expression (). Since the covariates were not available for all the samples and in the absence of strong and consistent effects of any of these factors, they were not used in the expression analysis. In pancreatic islets of non-T2D individuals, increasing counts of T2D-associated risk alleles of rs12255372 were associated with lower expression of several assays targeting C-terminal alternative exons of TCF7L2 in up to 26 samples of human pancreatic islets (with a significance for univariate linear model P = 0.002 for assay 'ex13-14', P = 0.003 for assay '13-13b', P = 0.010 for assay 'ex12-13' and P = 0.022 for assay 'ex13-13a' (). In a follow-up study, we performed expression analysis for seven assays detecting C-terminal exons of TCF7L2 in up to 24 additional samples of pancreatic islets (). In the joint analysis of up to 50 samples, expression of assays 'ex13-14' and 'ex13-13b', adjusted for sample set, remained lower in samples with increasing counts of T2D-associated risk alleles: for assay 'ex13-14' P = 0.018 for rs12255372 and P = 0.020 for rs7903146 (Table 2) and for assay 'ex13-13b' P = 0.009 for rs12255372 and P = 0.053 for rs7903146 (Table 2 and Fig. 6).
###end p 22
###begin p 23
###xml 34 39 <span type="species:ncbi:9606">human</span>
Expression of assay 'ex13-13b' in human pancreatic islets by rs12255372 and rs7903146 genotypes. Normalized expression of assay 'ex13-13b' is shown in Log 2 scale relative to a mean value of the whole set. Association was tested with univariate linear regression under an additive genetic model for SNPs and with adjustment for two sample sets.
###end p 23
###begin p 24
###xml 27 33 27 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T2F7L2</italic>
Sample characteristics and T2F7L2 expression by genotypes of SNPs in pancreatic islets
###end p 24
###begin p 25
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aExpression of assays, normalized to expression level of reference gene B2M, Log 2 scale, mean values are adjusted for sample set but not for multiple tests.
###end p 25
###begin p 26
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 79 80 79 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
*P-values for univariate linear model under an additive genetic model; in bold P-values <0.05.
###end p 26
###begin p 27
###xml 13 14 13 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 29 30 29 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 50 51 50 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 66 67 66 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 94 95 94 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 117 123 117 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 211 212 211 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 252 258 252 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 330 331 330 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
In pancreas (n = 46), colon (n = 128), monocytes (n = 65), liver (n = 62) and adipose tissue (n = 14), expression of TCF7L2 splicing forms was not associated with rs7903146 or rs12255372 (). In skeletal muscle (n = 25), expression of several assays of TCF7L2 was significantly increased in carriers of risk alleles of rs12255372 (P = 0.049-0.005, ) but the effect was not proportional to the counts of risk alleles.
###end p 27
###begin title 28
Test for association of expression of metabolic/endocrine factors with genotypes of rs7903146 and rs12255372
###end title 28
###begin p 29
The counts of T2D-associated risk alleles of rs12255372 and rs7903146 were not associated with mRNA expression of several metabolic/endocrine factors important for T2D and expressed in pancreatic islets, pancreas or colon, such as proinsulin, proglucagon, ghrelin/obestatin, somatostatin, pancreatic and duodenum homeobox 1 (PDX1), proliferating cell nuclear antigen (PCNA) and vasoactive intestinal peptide (VIP) ().
###end p 29
###begin title 30
###xml 58 64 58 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 75 80 <span type="species:ncbi:9606">human</span>
Test for correlation between expression of proinsulin and TCF7L2 assays in human pancreatic islets
###end title 30
###begin p 31
###xml 52 58 52 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 224 225 224 225 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 270 271 270 271 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 430 431 430 431 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 451 452 451 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 452 453 452 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 462 463 462 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 486 487 486 487 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 507 508 507 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 508 509 508 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 518 519 518 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 570 571 570 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP321TB3">3</xref>
###xml 624 625 624 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 83 88 <span type="species:ncbi:9606">human</span>
We also correlated the expression of proinsulin and TCF7L2 assays in 23 samples of human pancreatic islets in unstimulated conditions and in 12 samples incubated for 24 h in the media with normal glucose concentration (5.5 mm) and with high glucose concentration (16.7 mm), corresponding to glucose blood level of T2D individuals. Expression of proinsulin most strongly correlated with expression of assay 'ex13-13b' both in 5.5 mm glucose condition, r2 = 0.90, P < 0.0001 and in 16.7 mm glucose condition, r2 = 0.84, P = 0.00063, but not in unstimulated samples (Table 3). Limited by small sample set of pancreatic islets (n = 12), we did not address affects of each of SNPs on glucose-stimulated expression.
###end p 31
###begin p 32
###xml 54 60 54 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
Correlation between mRNA expression of proinsulin and TCF7L2 in pancreatic islets
###end p 32
###begin p 33
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 1 2 1 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 90 91 90 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 157 158 157 158 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
r2-Pearson correlation coefficient, NS-not significant, in bold-significant correlations, P < 0.05; Glucose-stimulated islets were incubated in 5.5 or 16.7 mm glucose media at 37degreesC for 24 h.
###end p 33
###begin title 34
DISCUSSION
###end title 34
###begin p 35
###xml 157 163 157 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 205 206 205 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C1">1</xref>
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C46">46</xref>
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C47">47</xref>
###xml 295 301 295 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 361 362 361 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C2">2</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C15">15</xref>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C16">16</xref>
###xml 414 416 414 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C22">22</xref>
###xml 556 562 556 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 617 623 617 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 712 718 712 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 981 987 981 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 566 571 <span type="species:ncbi:9606">human</span>
###xml 997 1002 <span type="species:ncbi:9606">human</span>
Family-based linkage studies identified a region on chromosome 10q25.3 as a locus associated with T2D and fine-mapping studies within this region identified TCF7L2 as a candidate gene for the association (1,46,47). Recent GWAS and follow-up studies confirmed several genetic variants within the TCF7L2 gene as the strongest risk factors for development of T2D (2-15) and impaired function of pancreatic islets (16-22). As the first step towards understanding the biology of this genetic association, we performed studies on splicing and mRNA expression of TCF7L2 in human tissues. We show here: (1) the expression of TCF7L2 alternative exons represents a tissue-specific signature; (2) a unique splicing form of TCF7L2 is expressed in pancreatic islets, pancreas and colon but not in other tissues examined here; (3) expression of this splicing form correlates with expression of proinsulin in glucose-stimulated pancreatic islets; (4) expression of alternatively spliced forms of TCF7L2 in eight human tissues examined here is not associated with T2D-associated risk variants rs12255372 and rs7903146.
###end p 35
###begin p 36
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C30">30</xref>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C31">31</xref>
###xml 260 266 260 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 601 603 601 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C48">48</xref>
###xml 604 606 604 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C50">50</xref>
###xml 624 630 624 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 811 813 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C51">51</xref>
###xml 942 944 939 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C52">52</xref>
###xml 1180 1182 1177 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C39">39</xref>
###xml 1183 1185 1180 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C41">41</xref>
###xml 1374 1376 1371 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C53">53</xref>
###xml 1377 1379 1374 1376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C55">55</xref>
###xml 1418 1424 1415 1421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 1603 1608 <span type="species:ncbi:9606">human</span>
Non-coding genetic variations have been shown to increase disease risk by altering levels of mRNA expression and splicing architecture of mRNA transcripts (30,31). In this study, we identified several types of potentially functional splicing variations within TCF7L2: alternative TSSs, alternative exons 3a and 4a encompassing the associated LD block; and alternative C-terminal exons 12, 13, 13a and 13b. Alternative TSSs can generate mRNA transcripts encoding proteins with opposing biological functions such as proliferation versus differentiation as described for LEF/TCF, c-Myc and p73 proteins (48-50). In the case of TCF7L2, the alternative promoters produce protein isoforms that can activate or repress the WNT pathway dependent on the presence of beta-catenin binding domain encoded by exons 1 and 2 (51). Alternative exons 3a and 4a are located within a protein region responsible for interaction with a Groucho repressor protein (52). The combinatorial tissue-specific inclusion of alternative C-terminal exons 12, 13, 13a and 13b can activate alternative stop codons within exons 13a, 13b or 14 and create protein isoforms with short, medium and long reading frames (39,41). The function of these protein isoforms is unclear; however, only the long isoforms have binding sites for the C-terminal binding protein (CTBP), a negative regulator of the WNT pathway (53-55). Therefore, all alternative forms of TCF7L2 could be functionally important. However, the splicing variations tested here were not significantly associated with T2D-associated risk variants rs12255372 and rs7903146 in the human tissues tested.
###end p 36
###begin p 37
###xml 202 208 202 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 387 393 387 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C56">56</xref>
###xml 552 558 552 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 560 562 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C19">19</xref>
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C21">21</xref>
###xml 854 856 854 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C54">54</xref>
###xml 857 859 857 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C57">57</xref>
###xml 933 939 933 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 1285 1286 1273 1274 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1311 1312 1299 1300 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1418 1419 1406 1407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 1419 1420 1407 1408 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1434 1435 1422 1423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1477 1483 1465 1471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 1674 1675 1662 1663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2168 2174 2156 2162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
A potentially biologically important observation in this study, though not strongly supported by statistics after adjustment for multiple tests, was a decrease in expression of two expression assays of TCF7L2, 'ex13-14' and 'ex13-13b', in pancreatic islets of carriers of T2D-associated risk variants rs12255372 and rs7903146. This observation is in line with a notion that depletion of TCF7L2 in pancreatic islets leads to increased apoptosis, decrease in proliferation and glucose-induced insulin secretion (56) found in carriers of risk variants of TCF7L2 (19-21). The assay 'ex13-14' detects a splicing form that encodes a protein with long reading frame and a CRARF protein domain formed upon splicing of exons 13 and 14. The CRARF domain is a potent activator of the WNT pathway and is the most conserved part of the TCF7L2 protein in all species (54,57). The assay 'ex13-13b' detects the most tissue-specific splicing form of TCF7L2 expressed in pancreatic islets, colon and at a lower level in pancreas but not in multiple samples representing liver, skeletal muscles, adipocytes, monocytes or lymphoblastoid cell lines tested here. Expression of this form in pancreatic islets was approximately30-fold higher than in pancreas (). In pancreatic islets cultured at normal (5.5 mm) or high glucose (16.7 mm) conditions, mRNA expression of proinsulin most strongly correlated with expression of assay 'ex13-13b' (r2 = 0.84-0.90, P < 0.00063), but not with other assays of TCF7L2. Perhaps, the splicing form detected by this assay marks a specific glucose-sensing or secretory cell type within pancreatic islets. Limited by a small sample set of glucose-induced islets (n = 12), we did not address effects of these SNPs on correlation with insulin expression. We did not observe association between counts of risk alleles of rs7903146 and rs12255372 and mRNA levels of proinsulin, proglucagon (the precursor of the insulinotropic hormone GLP-1) and several other metabolic/endocrine factors in pancreatic islets, pancreas and colon but this does not exclude the possibility that protein expression and secretion of these factors may be affected in carriers of the TCF7L2 risk variants.
###end p 37
###begin p 38
###xml 30 36 30 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 95 96 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</italic>
###xml 123 129 123 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 148 153 148 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C28">28</xref>
###xml 186 192 186 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 329 334 329 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C38">38</xref>
###xml 491 497 491 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 681 686 681 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 810 816 810 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 977 983 977 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 210 215 <span type="species:ncbi:9606">human</span>
The reports on association of TCF7L2 expression in human pancreatic islets and genotypes of T2D-associated variants within TCF7L2 are few. Lyssenko et al. (28) used the assay 'ex7-8' of TCF7L2 in 15 samples of human pancreatic islets and reported a significantly higher expression in carriers of rs7903146 risk genotypes. Osmark et al. (38) addressed the expression of several splicing forms in a set of 17 pancreatic islets but did not observe any association between expression of several TCF7L2 assays and genotypes of rs7903146. For several assays that targeted the same splicing forms ('ex3a-4', 'ex11-14', 'ex11-13', 'ex11-13a') we see the same results as reported by Osmark et al. The assays 'ex13-14' and 'ex13-13b' whose expression showed some evidence for association with T2D-associated variants of TCF7L2 in our study have not been previously used in any tissue. Additionally, we used larger sample sets for each tissue and for the first time studied expression of TCF7L2 in tissues such as pancreas, peripheral blood monocytes and colon.
###end p 38
###begin p 39
###xml 155 161 155 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 439 445 439 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 551 557 551 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 604 605 604 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 678 684 678 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 1286 1292 1286 1292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 1308 1314 1308 1314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 1346 1352 1346 1352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 1606 1612 1606 1612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 1672 1678 1672 1678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 1970 1972 1970 1972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C58">58</xref>
###xml 1973 1975 1973 1975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C59">59</xref>
###xml 67 72 <span type="species:ncbi:9606">Human</span>
We recognize the limitations of the approaches used in this study. Human tissue samples consist of multiple cell types that can exhibit diverse pattern of TCF7L2 expression. Tissue biopsies were taken during surgeries preceded by fasting and stress, thus these samples may not represent optimal physiological conditions for studies on T2D-related phenotypes. We attempted to identify and quantify the majority of splicing variation within TCF7L2. However, the analysis did not cover several minor splicing variations and yet unknown splicing forms of TCF7L2 that can exist and contribute to disease. The P-values for association between the counts of T2D-associated alleles and TCF7L2 expression were not adjusted for multiple testing. A Bonferroni correction would be overly stringent given the correlation between the 13 assays within each tissue. Our goal was to identify potential biologically important differences that should be tested in other sets of samples and with additional methods. We understand that with relatively small sample sets representing each tissue type, some of our results might be false-positives or false-negatives. Larger numbers of samples from each tissue type and, particularly, pancreatic islets, would increase the power to detect association between TCF7L2 expression and TCF7L2 SNP variants. Risk variants of TCF7L2 SNPs might be associated with several types of molecular changes relevant for T2D and our study addressed only one of these types, mRNA expression of alternative splicing forms. It is possible that there might be other important molecular phenotypes of TCF7L2 yet to be identified and examined. The C-terminal exons of TCF7L2 are located >100 kb away from the associated LD block. How the associated DNA variants can affect the mRNA expression and splicing at this distance, is not yet understood. A potential mechanism could be related to long-distance co-transcriptional regulation of mRNA expression and splicing (58,59).
###end p 39
###begin p 40
###xml 104 110 104 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 354 360 354 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 462 468 462 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
In conclusion, our findings provide new evidence of tissue-specific patterns of alternative splicing of TCF7L2. Moreover, we provide the first suggestive evidence that decreased expression of one ubiquitous and one rare tissue-specific alternative splicing forms of the gene in pancreatic islets may be associated with T2D-associated genetic variants of TCF7L2. Future studies should confirm and explore the observed association between genetic variation within TCF7L2, tissue-specific alternative splicing and risk of T2D.
###end p 40
###begin title 41
MATERIALS AND METHODS
###end title 41
###begin title 42
Tissue samples
###end title 42
###begin p 43
###xml 9 14 <span type="species:ncbi:9606">human</span>
###xml 267 272 <span type="species:ncbi:9606">Human</span>
###xml 686 689 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 935 940 <span type="species:ncbi:9606">Human</span>
Purified human pancreatic islets in the US set were obtained from the Islet Cell Resource Centers (IRB exemption number 3072) and the National Disease Research Interchange (IRB exemption number 3269) under IRB exemption by the National Institutes of Health Office of Human Subjects Research. Pancreatic islets were provided by Washington University, St. Louis, MO, USA; City of Hope National Medical Center, Duarte, CA, USA; University of Miami, Miami, FL, USA and the Joslin Diabetes Center, Boston, MA, USA. Information on age, sex, BMI, islets purity and viability, duration of cold ischemic time (time between pancreas removal and islet preparation), cause of death, T2D status and CMV infection was available for these samples. Pancreatic islets in the Swedish set were provided by the Nordic Network for Clinical Islet Transplantation by the courtesy of Dr Olle Korsgren at Uppsala University, Sweden and Dr Jalal Taneera at the Human Tissue laboratory at Lund University Diabetes Centre, Sweden.
###end p 43
###begin p 44
###xml 941 942 941 942 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 149 157 <span type="species:ncbi:9606">Children</span>
###xml 465 473 <span type="species:ncbi:9606">patients</span>
###xml 562 570 <span type="species:ncbi:9606">Children</span>
###xml 746 751 <span type="species:ncbi:9606">human</span>
###xml 1021 1026 <span type="species:ncbi:9606">human</span>
###xml 1349 1354 <span type="species:ncbi:9606">human</span>
###xml 1380 1385 <span type="species:ncbi:9606">human</span>
###xml 1414 1419 <span type="species:ncbi:9606">human</span>
Human pancreas, colon and liver samples were biopsies obtained from the University of Minnesota Tissue Procurement Center, Minneapolis, MN, USA, and Children's Hospital, Boston, MA, USA. For the majority of these samples clinical reports indicating primary diagnosis, T2D status, age, sex and BMI were available. All tissue biopsies were non-malignant tissues as confirmed by pathology reports. Skeletal muscles biopsies were collected from healthy individuals and patients with Duchenne or Becker Muscular dystrophy at the Research Center for Genetic Medicine, Children's National Medical Center, Washington, DC, USA. Information about age, sex, BMI and disease status was available for these samples. Samples of fresh blood were from anonymous human blood donors and information about age and sex of the subjects were provided by the NIH Clinical Center Division of Transfusion Medicine. Monocytes were separated from fresh blood with CD14+-coated magnetic MicroBeads with AutoMacs (Miltenyi Biotec). Frozen samples of human subcutaneous adipose tissue were purchased from Zen-Bio, Inc. and information on age, sex, BMI and T2D status was available for these samples. IRB approval for de-identified tissues was obtained from all Institutions involved. All samples with known T2D were excluded (five samples in the whole set of all tissues). 293T (human embryonic kidney), HeLa (human cervical carcinoma), HepG2 (human hepatocellular carcinoma) were purchased from ATCC (the American Type Culture Collection) and lymphoblastoid cell lines from CEPH (Centre d' Etude du Polymorphisme Humain) individuals were purchased from Coriell cell repositories.
###end p 44
###begin title 45
Glucose-stimulated pancreatic islets
###end title 45
###begin p 46
###xml 136 137 136 137 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 253 254 253 254 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
Twelve samples from the US set were split in six aliquots each. Three aliquots were incubated in CMRL-1066 cell culture media with 5.5 mm glucose while other three aliquots of the same samples were incubated with CMRL-1066 cell culture media with 16.7 mm glucose for 24 h.
###end p 46
###begin title 47
Preparation of DNA and RNA
###end title 47
###begin p 48
###xml 507 512 <span type="species:ncbi:9606">human</span>
DNA from tissue samples was prepared with DNeasy Kit (Qiagen) except for adipose tissue where DNA was recovered after RNA preparation according to Trizol protocol (Invitrogen). RNA was prepared with Trizol (Invitrogen) followed by RNeasy kit (Qiagen). RNA from the second set of pancreatic islets RNA was isolated using the AllPrep DNA/RNA Mini Kit (Qiagen). No sign of RNA degradation was observed using agarose gel electrophoresis and Experion DNA 1 K gel chips (Bio-Rad). RNA samples from all additional human tissues and cDNA from purified blood fractions (Multiple Tissue cDNA panels) were purchased from Clontech.
###end p 48
###begin title 49
Genotyping
###end title 49
###begin p 50
Genotyping was performed with an allelic-discrimination TaqMan assays for rs12255372 and rs7903146 and the Universal Genotyping Master Mix (Applied Biosystems). Alternatively or as an additional control, genotyping was performed by primer extension method using a Sequenom MALDI-TOF platform (Broad Institute).
###end p 50
###begin title 51
cDNA preparation and qPCR
###end title 51
###begin p 52
###xml 219 220 211 212 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 223 225 215 217 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18</sub>
###xml 246 247 234 235 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 279 281 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP321C38">38</xref>
###xml 715 718 695 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B2M</italic>
###xml 743 748 722 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 879 882 858 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B2M</italic>
###xml 900 905 879 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
cDNA was prepared in a 20 microl volume with 500 ng of DNase-treated total RNA with use of random hexamers and Superscript III reverse transcriptase (Invitrogen) (set 1) or with the Qiagen Omniscript RT kit with 1 microm dT18 oligomer and 3 microm random hexamer primers (set 2 (38)). DNA was diluted with water to 200 microl and an equivalent of 5-10 ng of total RNA was used for each reaction (except for lymphoblastoid cell lines where 2 microg of total RNA was used as a starting amount). All reactions were run in three or four technical replicates. Standard deviations of below 0.2 Ct between the replicates were acceptable for high-expressing assays and 0.5 Ct for low-expressing assays. Endogenous controls B2M (ss-2 microglobulin) or GAPDH (Glyceraldehyde-3-phosphate dehydrogenase) were measured from the same cDNA preparations with expression assays Hs00187842_m1 for B2M and 4333764F for GAPDH (Applied Biosystems). All primers for custom-designed assays were created to amplify only from cDNA and TaqMan probes were placed on the junctions between specific exons ( for primer sequences and assay information). All quantitative PCR reactions were performed in a 10 microl volume using the 7900 Real-Time PCR System (ABI) in 384 well plates. Universal Expression Master Mix was used for all expression studies with TaqMan probes according to standard conditions (Applied Biosystems). The reactions with 2xSYBR Green PCR mix (Qiagen) and specific primers were carried out for 15 min at 95degreesC, followed by 40 cycles of 15 s at 95degreesC, 15 sec at 59degreesC and 45 s at 72degreesC. Post-PCR melting curve analysis was used after each run. Initially, gel-purified PCR fragments were sequenced to ensure the specificity of amplification and correct splicing.
###end p 52
###begin title 53
Data analysis
###end title 53
###begin p 54
###xml 283 292 283 292 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">reference</sub>
###xml 297 304 297 304 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">target,</sub>
###xml 442 448 442 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 616 621 616 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(dCt)</sup>
###xml 621 622 621 622 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</sub>
###xml 880 886 880 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
Values from three to four technical replicates for each expression assay were averaged and normalized to the expression levels of BM2 and GAPDH run in separate reactions from the same cDNA preparation. Relative differences in expression were calculated according to formula: dCt = Ctreference - Cttarget, where 'reference' represents levels of expression (Ct values) of B2M, GAPDH or both genes and 'target' represents level of expression of TCF7L2 assays; negative Ct means that a target is expressed lower than a reference gene; fold difference in expression between a reference and a target can be calculated as 2(dCt). Within each tissue and assay, the log-transformed expression values were tested for normality. The associations between specified variables were tested using univariate linear model with inclusion of covariates where indicated (SPSS 16.0 software). The SNP-TCF7L2 expression or SNP-T2D related gene expression analyses were used according to an additive genetic model. The PCA analysis on mean-centered expression values for selected assays was performed with GenEx software (MultiD). We estimated the fold-difference in gene expression between samples with and without the T2D associated risk genotype that could be detected with 80 or 95% power with a type 1 error rate of 5%. For the power calculations for assay 'ex7-8' have been performed with observed standard deviation for this assay in each tissue and the number of samples with and without T2D associated risk genotypes (StatMate software, GraphPad). The power analysis differs from our regression analysis of gene expression and allele count, but is a good approximation when the less frequent genotype homozygote samples are rare.
###end p 54
###begin p 55
###xml 401 407 401 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
For each sample of glucose-stimulated pancreatic islets, expression values of technical triplicates were averaged and then normalized to expression of endogenous control, B2M. The normalized values were averaged for three aliquots of the same samples. Therefore, for each sample and experimental condition expression was measured nine times. The Pearson correlation coefficients between expression of TCF7L2 assays and proinsulin were calculated with SPSS 16.0.
###end p 55
###begin title 56
5'RACE and analysis of splicing forms
###end title 56
###begin p 57
###xml 677 683 677 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
5'RACE cDNA from multiple tissues was prepared from 200 to 500 ng of total RNA with use of the BD SMART RACE cDNA amplification kit (Clontech). PCR fragments were amplified with universal primers included in the kit and several gene-specific specific primers. PCR fragments were gel-purified (Qiaquick, Qiagen) and sequenced with BD Terminator chemistry (Applied Biosystems). The full-length cDNA fragments from the first ATG translation start site in exon 1 and to the most distant stop codon within exon 14 were amplified by a proof-reading KOD polymerase (Novagen), cloned into pFC8A vector (Promega) and multiple individual clones were sequenced. Expression constructs for TCF7L2 splicing forms are available upon request.
###end p 57
###begin title 58
SUPPLEMENTARY MATERIAL
###end title 58
###begin p 59
.
###end p 59
###begin title 60
[Supplementary Data]
###end title 60
###begin title 61
FUNDING
###end title 61
###begin p 62
###xml 29 32 29 32 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NIH</funding-source>
###xml 39 54 39 54 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1R21DK078029-01</award-id>
###xml 110 113 110 113 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NIH</funding-source>
###xml 366 369 366 369 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NIH</funding-source>
The project was supported by NIH grant 1R21DK078029-01 (JH), Intramural Research Programs of NHGRI and NCI of NIH. Work at LUDC was funded by grants from the Swedish Research Council, the Wallenberg Foundation and the Novo Nordisk Foundation. Funding to pay the Open Access publication charges for this article was provided by the intramural research program of NCI/NIH.
###end p 62
###begin title 63
ACKNOWLEDGEMENTS
###end title 63
###begin p 64
###xml 370 375 <span type="species:ncbi:9606">human</span>
###xml 384 389 <span type="species:ncbi:9606">Human</span>
###xml 579 584 <span type="species:ncbi:9606">Human</span>
A special thank you to Marjorie Carlson and Mona Svardh for technical assistance, Sara Bowell and Drs Ralph Powell, Amy Skubitz, Stephen Schmechel, and Charlie Moldow for facilitation of the access to tissue samples through the University of Minnesota Tissue Procurement Facility, to Islet Cell Resource Centers and the National Disease Research Interchange Network for human islets. Human islets (Swedish cohort) were provided by the Nordic Network for Clinical Islet Transplantation by the courtesy of Dr Olle Korsgren at Uppsala University, Sweden and Dr Jalal Taneera at the Human Tissue laboratory at Lund University Diabetes Centre, Sweden. LPO was a Wenner-Gren Fellow.
###end p 64
###begin p 65
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of Interest statement</italic>
Conflict of Interest statement. None declared.
###end p 65
###begin title 66
REFERENCES
###end title 66
###begin article-title 67
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
###end article-title 67
###begin article-title 68
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
###end article-title 68
###begin article-title 69
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
###end article-title 69
###begin article-title 70
Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes
###end article-title 70
###begin article-title 71
###xml 112 117 <span type="species:ncbi:9606">women</span>
###xml 122 125 <span type="species:ncbi:9606">men</span>
Variant of transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in large cohorts of U.S. women and men
###end article-title 71
###begin article-title 72
Association of variants of transcription factor 7-like 2 (TCF7L2) with susceptibility to type 2 diabetes in the Dutch Breda cohort
###end article-title 72
###begin article-title 73
Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample
###end article-title 73
###begin article-title 74
Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals
###end article-title 74
###begin article-title 75
TCF7L2 polymorphisms are associated with type 2 diabetes in northern Sweden
###end article-title 75
###begin article-title 76
Variants of the transcription factor 7-like 2 gene (TCF7L2) are strongly associated with type 2 diabetes but not with the metabolic syndrome in the MONICA/KORA surveys
###end article-title 76
###begin article-title 77
###xml 129 132 <span type="species:ncbi:9606">men</span>
###xml 137 142 <span type="species:ncbi:9606">women</span>
Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European Whites, Indian Asians and Afro-Caribbean men and women
###end article-title 77
###begin article-title 78
Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution
###end article-title 78
###begin article-title 79
Association analysis of 6,736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk
###end article-title 79
###begin article-title 80
Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance
###end article-title 80
###begin article-title 81
Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population
###end article-title 81
###begin article-title 82
Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms
###end article-title 82
###begin article-title 83
Variation of the transcription factor 7-like 2 (TCF7L2) gene predicts impaired fasting glucose in healthy young adults: the Cardiovascular Risk in Young Finns Study
###end article-title 83
###begin article-title 84
Association of TCF7L2 gene polymorphisms with reduced acute insulin response in Hispanic Americans
###end article-title 84
###begin article-title 85
###xml 124 129 <span type="species:ncbi:9606">women</span>
Polymorphism in the transcription factor 7-like 2 (TCF7L2) gene is associated with reduced insulin secretion in nondiabetic women
###end article-title 85
###begin article-title 86
Transcription factor 7-like 2 (TCF7L2) is associated with gestational diabetes mellitus and interacts with adiposity to alter insulin secretion in Mexican Americans
###end article-title 86
###begin article-title 87
Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion
###end article-title 87
###begin article-title 88
TCF7L2 variants are associated with increased proinsulin/insulin ratios but not obesity traits in the Framingham Heart Study
###end article-title 88
###begin article-title 89
###xml 178 181 <span type="species:ncbi:9606">men</span>
Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5 327 non-diabetic Finnish men
###end article-title 89
###begin article-title 90
TCF/LEF factor earn their wings
###end article-title 90
###begin article-title 91
TCF: Lady Justice casting the final verdict on the outcome of Wnt signalling
###end article-title 91
###begin article-title 92
###xml 73 77 <span type="species:ncbi:10090">mice</span>
Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4
###end article-title 92
###begin article-title 93
TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta
###end article-title 93
###begin article-title 94
Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes
###end article-title 94
###begin article-title 95
###xml 217 220 <span type="species:ncbi:9606">men</span>
The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men
###end article-title 95
###begin article-title 96
###xml 96 101 <span type="species:ncbi:9606">human</span>
Identification of common genetic variants that account for transcript isoform variation between human populations
###end article-title 96
###begin article-title 97
A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus
###end article-title 97
###begin article-title 98
###xml 65 70 <span type="species:ncbi:9606">human</span>
Expression of the transcription factor 7-like 2 gene (TCF7L2) in human adipocytes is down regulated by insulin
###end article-title 98
###begin article-title 99
Impact of TCF7L2 rs7903146 on Insulin Secretion and Action in Young and Elderly Danish Twins
###end article-title 99
###begin article-title 100
###xml 118 130 <span type="species:ncbi:9606">participants</span>
Transcription factor 7-like 2 polymorphisms and type 2 diabetes, glucose homeostasis traits and gene expression in US participants of European and African descent
###end article-title 100
###begin article-title 101
###xml 82 87 <span type="species:ncbi:9606">human</span>
Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes
###end article-title 101
###begin article-title 102
TCF7L2 is associated with high serum triacylglycerol and differentially expressed in adipose tissue in families with familial combined hyperlipidaemia
###end article-title 102
###begin article-title 103
###xml 30 38 <span type="species:ncbi:9606">patients</span>
TCF7L2 expression in diabetic patients undergoing bariatric surgery
###end article-title 103
###begin article-title 104
###xml 46 51 <span type="species:ncbi:9606">human</span>
Unique splicing pattern of the TCF7L2 gene in human pancreatic islets
###end article-title 104
###begin article-title 105
###xml 41 46 <span type="species:ncbi:9606">human</span>
Assignment of the TCF-4 gene (TCF7L2) to human chromosome band 10q25.3
###end article-title 105
###begin article-title 106
###xml 57 62 <span type="species:ncbi:9606">human</span>
Differential expression and splicing isoform analysis of human Tcf-4 transcription factor in brain tumors
###end article-title 106
###begin article-title 107
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma
###end article-title 107
###begin article-title 108
Extensive alternative splicing and dual promoter usage generate Tcf-1 protein isoforms with differential transcription control properties
###end article-title 108
###begin article-title 109
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing
###end article-title 109
###begin article-title 110
Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer
###end article-title 110
###begin article-title 111
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs
###end article-title 111
###begin article-title 112
Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2
###end article-title 112
###begin article-title 113
Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans
###end article-title 113
###begin article-title 114
Wnt activation and alternative promoter repression of LEF1 in colon cancer
###end article-title 114
###begin article-title 115
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 74 97 <span type="species:ncbi:7227">Drosophila melanogaster</span>
Human c-Myc isoforms differentially regulate cell growth and apoptosis in Drosophila melanogaster
###end article-title 115
###begin article-title 116
###xml 88 93 <span type="species:ncbi:9606">human</span>
DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors
###end article-title 116
###begin article-title 117
Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma
###end article-title 117
###begin article-title 118
All Tcf HMG box transcription factors interact with Groucho-related co-repressors
###end article-title 118
###begin article-title 119
C-terminal-binding protein directly activates and represses Wnt transcriptional targets in Drosophila
###end article-title 119
###begin article-title 120
A unique DNA binding domain converts T-cell factors into strong Wnt effectors
###end article-title 120
###begin article-title 121
A genome-wide RNAi screen for Wnt/beta-catenin pathway components identifies unexpected roles for TCF transcription factors in cancer
###end article-title 121
###begin article-title 122
###xml 75 80 <span type="species:ncbi:9606">human</span>
Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets
###end article-title 122
###begin article-title 123
A new beta-catenin-dependent activation domain in T cell factor
###end article-title 123
###begin article-title 124
Cotranscriptional coupling of splicing factor recruitment and precursor messenger RNA splicing in mammalian cells
###end article-title 124
###begin article-title 125
Multiple links between transcription and splicing
###end article-title 125

